Cyclophosphamide Versus Obinutuzumab for the Treatment of Anti-MDA5 Positive Inflammatory Myopathy with Interstitial Lung Disease: A Study Protocol and Literature Review

Ho So,Chi Chiu Mok

Cyclophosphamide Versus Obinutuzumab for the Treatment of Anti-MDA5 Positive Inflammatory Myopathy with Interstitial Lung Disease: A Study Protocol and Literature Review

2019

Ho So
Chi Chiu Mok

In patients with idiopathic inflammatory myopathy, the presence of the melanoma differentiation-associated gene 5 (MDA5) antibody carries an extremely poor prognosis as a result of the associated i...

Keywords:

MDA5
Interstitial lung disease
Obinutuzumab
Gastroenterology
Cyclophosphamide
Inflammatory myopathy
Medicine
Internal medicine
Extremely Poor
Antibody
Melanoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations